OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Novavax Heterologous Coronavirus Disease 2019 Booster Demonstrates Lower Reactogenicity Than Messenger RNA: A Targeted Review
Anthony M. Marchese, Matthew D. Rousculp, John C. Macbeth, et al.
The Journal of Infectious Diseases (2023) Vol. 230, Iss. 2, pp. e496-e502
Open Access | Times Cited: 8
Anthony M. Marchese, Matthew D. Rousculp, John C. Macbeth, et al.
The Journal of Infectious Diseases (2023) Vol. 230, Iss. 2, pp. e496-e502
Open Access | Times Cited: 8
Showing 8 citing articles:
Burden and Impact of Reactogenicity among Adults Receiving COVID-19 Vaccines in the United States and Canada: Results from a Prospective Observational Study
Matthew D. Rousculp, Kelly Hollis, Ryan Ziemiecki, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 83-83
Open Access | Times Cited: 7
Matthew D. Rousculp, Kelly Hollis, Ryan Ziemiecki, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 83-83
Open Access | Times Cited: 7
The Second Life for Unused COVID-19 Vaccines: Towards Biosensing Application
Vincentas Mačiulis, Asta Lučiūnaitė, Mantvydas Usvaltas, et al.
Talanta (2025), pp. 127647-127647
Closed Access
Vincentas Mačiulis, Asta Lučiūnaitė, Mantvydas Usvaltas, et al.
Talanta (2025), pp. 127647-127647
Closed Access
Cost-Effectiveness of Introducing Nuvaxovid to COVID-19 Vaccination in the United Kingdom: A Dynamic Transmission Model
Clive Pritchard, Lucie Kutikova, Richard Pitman, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 187-187
Open Access
Clive Pritchard, Lucie Kutikova, Richard Pitman, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 187-187
Open Access
The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose
Nadia Mazarakis, Zheng Quan Toh, Eleanor Neal, et al.
Journal of Infection (2025), pp. 106447-106447
Open Access
Nadia Mazarakis, Zheng Quan Toh, Eleanor Neal, et al.
Journal of Infection (2025), pp. 106447-106447
Open Access
Reactogenicity Differences between Adjuvanted, Protein-Based and Messenger Ribonucleic Acid (mRNA)-Based COVID-19 Vaccines
Matthew D. Rousculp, Kelly Hollis, Ryan Ziemiecki, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 802-802
Open Access | Times Cited: 2
Matthew D. Rousculp, Kelly Hollis, Ryan Ziemiecki, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 802-802
Open Access | Times Cited: 2
Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine
David G. Alleva, Eline A. Feitsma, Yester F. Janssen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
David G. Alleva, Eline A. Feitsma, Yester F. Janssen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Reactogenicity Differences between COVID-19 Vaccines: A Prospective Observational Study in the United States and Canada
Matthew D. Rousculp, Kelly Hollis, Ryan Ziemiecki, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Matthew D. Rousculp, Kelly Hollis, Ryan Ziemiecki, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Intranasal Delivery of Quillaja brasiliensis Saponin-Based Nanoadjuvants Improve Humoral Immune Response of Influenza Vaccine in Aged Mice
Fernando Silveira, Florencia García, Gabriel Garcı́a, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 902-902
Open Access
Fernando Silveira, Florencia García, Gabriel Garcı́a, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 902-902
Open Access
